Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Interleukin-6
100%
MCF-7 Cells
100%
Aryl Hydrocarbon Receptor
100%
Inflammatory Pathways
100%
Synergistic Induction
100%
Interleukin-1β
44%
Interleukin-6 Expression
44%
Tumor Cells
33%
Phorbol 12-myristate 13-acetate
33%
Breast
11%
Receptor Activation
11%
Signal Transduction
11%
Small Interfering RNA (siRNA)
11%
Chromatin
11%
Receptor-mediated
11%
Prototypic
11%
Tumor Promotion
11%
MCF-7
11%
Cancer Cells
11%
Responsive Genes
11%
Transcriptional Regulation
11%
MRNA Expression
11%
Plethora
11%
Transcriptional Activity
11%
Chromatin Immunoprecipitation (ChIP)
11%
Cytochrome P450 1A1 (CYP1A1)
11%
Treatment Results
11%
Response to Treatment
11%
Biological Response
11%
Pleiotropic Cytokine
11%
Aryl Hydrocarbon Receptor Activity
11%
Putative Drug Targets
11%
Interleukin-6 Levels
11%
Cell Environment
11%
Antitumor Properties
11%
Immune Homeostasis
11%
Mechanistic Knowledge
11%
Biochemistry, Genetics and Molecular Biology
Interleukin 6
100%
Aryl Hydrocarbon Receptor
100%
Interleukin-1
33%
Myristic Acid
25%
RELA
16%
Cytokine
8%
Homeostasis
8%
Signal Transduction
8%
Promoter Region
8%
Cancer Cell
8%
Small Interfering RNA
8%
Chromatin Immunoprecipitation
8%
Immunocompetent Cell
8%
Messenger RNA
8%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 6
100%
Aromatic Hydrocarbon Receptor
100%
Neoplasm
25%
12-O-Tetradecanoylphorbol-13-Acetate
25%
Malignant Neoplasm
8%
Tumor Promotion
8%
Cytokine
8%
Small Interfering RNA
8%
Chromatin Immunoprecipitation
8%
Messenger RNA
8%
Immunology and Microbiology
Immune Cell Homeostasis
8%